Technical assessment of the first 20 years of research using mouse embryonic stem cell lines

Stem Cells

Volumn 22, Issue 7, 2004, Pages 1168-1180

  Downing, Gregory J ^a   Battey Jr , James F ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

Author keywords

Discovery; Homologous recombination; Mouse embryonic stem cell; Technology

Indexed keywords

TRANSCRIPTION FACTOR;

CELL CYCLE; CELL LINE; CELL MATURATION; CELL NUCLEUS TRANSPLANTATION; CLONING; DRUG DEVELOPMENT; EMBRYO CELL; GENE CONSTRUCT; GENE FUNCTION; HOMEOBOX; HOMOLOGOUS RECOMBINATION; HUMAN; MEDICAL RESEARCH; NONHUMAN; SHORT SURVEY; STEM CELL; TRANSGENIC ANIMAL;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; CELL NUCLEUS; CELLS, CULTURED; CLONING, MOLECULAR; EMBRYO; GENES, HOMEOBOX; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECOMBINATION, GENETIC; STEM CELLS; TIME FACTORS; TRANSCRIPTION FACTORS;

ANIMALIA; RODENTIA;

EID: 10444228229     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2004-0101     Document Type: Short Survey

References (136)

1. Sherman MI. The culture of cells derived from mouse blastocysts. Cell 1975;5:343-349.
2. Martin GR. Teratocarcinomas and mammalian embryogenesis. Science 1980;209:768-776.
3. Stevens LC. The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Dev Biol 1970;21:364-382.
4. Stevens LC. A new inbred subline of mice (129-terSv) with a high incidence of spontaneous congenital testicular teratomas. J Natl Cancer Inst 1973;50:235-242.
5. Stevens LC. Animal model of human disease: benign cystic and malignant ovarian teratoma. Am J Pathol 1976;85:809-813.
6. Stevens LC, Varnum DS, Eicher EM. Viable chimeras produced from normal and parthenogenetic mouse embryos. Nature 1977;269:515-517.
7. Stevens LC. Totipotent cells of parthenogenetic origin in a chimaeric mouse. Nature 1978;276:266-267.
8. Moustafa LA, Brinster RL. Induced chimaerism by transplanting embryonic cells into mouse blastocysts. J Exp Zool 1972;181:193-201.
9. Brinster RL. The effect of cells transferred into the mouse blastocyst on subsequent development. J Exp Med 1974;140:1049-1056.
10. Brinster RL. Participation of teratocarcinoma cells in mouse embryo development. Cancer Res 1976;36:3412-3414.
11. Watanabe T, Dewey MJ, Mintz B. Teratocarcinoma cells as vehicles for introducing specific mutant mitochondrial genes into mice. Proc Natl Acad Sci U S A 1978;75:5113-5117.
12. Solter D, Skreb N, Damjanov I. Extrauterine growth of mouse egg-cylinders results in malignant teratoma. Nature 1970;227:503-504.
13. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981;78:7634-7638.
14. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-156.
15. Hogan B, Constantini F, Lacy E. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1986.
16. Lovell-Badge RH, Bygrave AE, Bradley A et al. Transformation of embryonic stem cells with the human type-II collagen gene and its expression in chimeric mice. Cold Spring Harb Symp Quant Biol 1985;50:707-711.
17. Thomas KR, Capecchi MR. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987;51:503-512.
18. Kuehn MR, Bradley A, Robertson EJ et al. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 1987;326:295-298.
19. Smithies O, Gregg RG, Boggs SS et al. Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 1985;317:230-234.
20. Doetschman T, Gregg RG, Maeda N et al. Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 1987;330:576-578.
21. Gossler A, Doetschman T, Korn R et al. Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc Natl Acad Sci U S A 1986;83:9065-9069.
22. Robertson E, Bradley A, Kuehn M et al. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature (London) 1986;323:445-448.
23. Thompson S, Clarke AR, Pow AM et al. Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells. Cell 1989;56:313-321.
24. Saiki RK, Scharf S, Faloona F et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle-cell anemia. Science 1985;230:1350-1354.
25. Erlich HA, Gelfand DH, Saiki RK. Specific DNA amplification. Nature (London) 1988;331:461-462.
26. Mansour SL, Thomas KR, Capecchi MR. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature (London) 1988;336:348-352.
27. Jasin M, Berg P. Homologous integration in mammalian cells without target gene selection. Genes Develop 1988;2:1353-1363.
28. Sedivy JM, Sharp PA. Positive genetic selection for gene disruption in mammalian cells by homologous recombination. Proc Natl Acad Sci U S A 1989;86:227-231.
29. Babinet C, Cohen-Tannoudji M. Genome engineering via homologous recombination in mouse embryonic stem (ES) cells: an amazingly versatile tool for the study of mammalian biology. An Acad Bras Cienc 2001;73:365-383.
30. Torres M. The use of embryonic stem cells for the genetic manipulation of the mouse. Curr Top Dev Biol 1998;36:99-114.
31. Muller MB, Keck ME. Genetically engineered mice for studies of stress-related clinical conditions. J Psychiatr Res 2002;36:53-76.
32. Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 2003;10:63-71.
33. Holschneider DP, Chen K, Seif I et al. Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B. Brain Res Bull 2001;56:453-462.
34. Harada N, Tamai Y, Ishikawa T et al. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J 1999;18:5931-5942.
35. Kulkarni RN, Bruning JC, Winnay JN et al. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999;96:329-339.
36. Chisaka O, Capecchi MR. Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5. Nature 1991;350:473-479.
37. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990;345:78-80.
38. Joyner AL, Herrup K, Auerbach BA et al. Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox. Science 1991;251:1239-1243.
39. Koller BH, Marrack P, Kappler JW et al. Normal development of mice deficient in B2M, MHC class I proteins, and CD8+ T cells. Science 1990;248:1227-1229.
40. McMahon AP, Bradley A. The wnt-1(int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 1990;62:1073-1085.
41. Mucenski ML, McLain K, Kier AB et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 1991;65:677-689.
42. Pevny L, Simon MC, Robertson E et al. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 1991;349:257-260.
43. ml mutation show poor viability and depletion of selected B and T cell populations. Cell 1991;65:1165-1175.
44. Soriano P, Montgomery C, Geske R et al. Targeted disruption of the c-src proto-oncogene leads to osteoporosis in mice. Cell 1991;64:693-702.
45. Tybulewicz VLJ, Crawford CE, Jackson PK et al. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 1991;65:1153-1163.
46. Thomas KR, Capecchi MR. Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. Nature 1990;346:847-850.
47. + cytolytic T cells. Nature 1990;344:742-746.
48. Koller BH, Kim HS, Latour AM et al. Toward an animal model of cystic fibrosis: targeted interruption of exon 10 of the cystic fibrosis transmembrane regulator gene in embryonic stem cells. Proc Natl Acad Sci U S A 1991;88:10730-10734.
49. Ratcliff R, Evans MJ, Cuthbert AW et al. Production of a severe cystic fibrosis mutation in mice by gene targeting. Nat Genet 1993;4:35-41.
50. Rapaport D, Fuchs O, Nudel U et al. Expression of the Duchenne muscular dystrophy gene products in embryonic stem cells and their differentiated derivatives. J Biol Chem 1992;267:21289-21292.
51. Colucci-Guyon E, Portier M-M, Dunia I et al. Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 1994;79:679-694.
52. Tajbakhsh S, Rocancourt D, Buckingham M. Muscle progenitor cells failing to respond to positional cues adopt non-myogenic fates in myf-5 null mice. Nature 1996;384:266-270.
53. Wang Y, Jaenisch R. Myogenin can substitute for Myf5 in promoting myogenesis but less efficiently. Development 1997;124:2507-2513.
54. Suda Y, Nakabayashi J, Matsuo I et al. Functional equivalency between Otx2 and Otx1 in development of the rostral head. Development 1999;126:743-757.
55. Bozza T, McGann JP, Mombaerts P et al. In vivo imaging of neuronal activity by targeted expression of a genetically encoded probe in the mouse. Neuron 2004;42:9-21.
56. Sauer B. Inducible gene targeting in mice using the Cre/lox system. Methods 1998;14:381-392.
57. Cohen-Tannoudji M, Babinet C. Beyond "knock-out" mice: new perspectives for the programmed modification of the mammalian genome. Mol Hum Reprod 1998;4:929-938.
58. Gu H, Marth JD, Orban PC et al. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 1994;265:103-106.
59. Smith AG, Heath JK, Donaldson DD et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988;336:688-690.
60. Williams RL, Hilton DJ, Pease S et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988;336:684-687.
61. Nichols J, Evans EP, Smith AG. Establishment of germline-competent embryonic seem (ES) cells using differentiation inhibiting activity. Development 1990;110:1341-1348.
62. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994;79:551-555.
63. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-330.
64. Savatier P, Lapillonne H, van Grunsven LA et al. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor upregulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene 1996;12:309-322.
65. Jirmanova L, Afanassieff M, Gobert-Gosse S et al. Differential contributions of ERK and P13-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells. Oncogene 2002;21:5515-5528.
66. Menon SG, Sarsour EH, Spitz DR et al. Redox regulation of the G1 to S phase transition in the mouse embryo fibroblast cell cycle. Cancer Res 2003;63:2109-2117.
67. Bai S, Goodrich D, Thron CD et al. Theoretical and experimental evidence for hysteresis in cell proliferation. Cell Cycle 2003;2:46-52.
68. Doetschman TC, Eistetter H, Katz M et al. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morph 1985;87:27-45.
69. Risau W, Sariola H, Zerwes HG et al. Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 1988;102:471-478.
70. Wang R, Clark R, Bautch VL. Embryonic stem cell-derived cystic embryoid bodies form vascular channels: an in vitro model of blood vessel development. Development 1992;114:303-316.
71. Folkman J, D'Amore PA. Blood vessel formation: what is its molecular basis? Cell 1996;87:1153-1155.
72. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nature Med 2000;6:389-395.
73. Hirashima M, Ketaoka H, Nishikawa S et al. Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood 1999;93:1253-1263.
74. Yamashita J, Itoh H, Hirashima M et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000;408:92-96.
75. Lumelsky N, Blondel O, Laeng P et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001;292:1389-1394.
76. Lee SH, Lumelsky N, Studer L et al. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 2000;18:675-679.
77. McGinnis W, Krumlauf R. Homeobox genes and axial patterning. Cell 1992;68:283-302.
78. Tsonis PA, Adamson ED. Specific expression of homeobox-containing genes during induced differentiation of embryonal carcinoma cells. Biochem Biophys Res Commun 1986;137:520-527.
79. Colberg-Poley AM, Puschel AW, Dony C et al. Post-transcriptional regulation of a murine homeobox gene transcript in F9 embryonal carcinoma cells. Differentiation 1987;35:206-211.
80. Eistetter HR. A mouse pluripotent embryonal stem cell line stage-specifically regulates expression of homeo-box containing DNA sequences during differentiation in vitro. Eur J Cell Biol 1987;45:315-321.
81. Thomas PQ, Rathjen PD. HES-1, a novel homeobox gene expressed by murine embryonic stem cells, identifies a new class of homeobox genes. Nucleic Acids Res 1992;20:5840.
82. Lyons I, Parsons LM, Hartley L et al. Myogenic and morphogenic defects in the heart tubes of murine embryos lacking the homeobox gene Nkx2-5. Genes Dev 1995;9:1654-1666.
83. LeMouellic H, Lallemand Y, Brulet P. Targeted replacement of the homeobox gene Hox-3.1 by the Escherichia coli lacZ in mouse chimeric embryos. Proc Natl Acad Sci U S A 1990;87:4712-4716.
84. Le Mouellic H, Lallemand Y, Brulet P. Homeosis in the mouse induced by a null mutation in the Hox-3.1 gene. Cell 1992;69:251-264.
85. Chisaka O, Musci TS, Capecchi MR. Developmental defects of the ear, cranial nerves and hindbrain resulting from targeted disruption of the mouse homeobox gene Hox-1.6. Nature 1992;355:516-520.
86. Komuro I, Izumo S. Csx: a murine heart homeobox-containing gene specifically expressed in the developing heart. Proc Natl Acad Sci U S A 1993;90:8145-8149.
87. Sasaki AW, Doskow J, MacLeod CL et al. The oncofetal gene Pem encodes a homeodomain and is regulated in primordial and pre-muscle stem cells. Mech Dev 1991;34:155-164.
88. Fan Y, Melhem MF, Chaillet JR. Forced expression of the homeobox-containing gene Pem blocks differentiation in embryonic cells. Dev Biol 1999;210:481-496.
89. Akam M. Hox and HOM: homologous gene clusters in insects and vertebrates. Cell 1989;57:347-349.
90. Okamoto K, Okazawa H, Okuda A et al. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 1990;60:461-472.
91. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000;24:372-376.
92. Pesce M, Gross MK, Scholer HR. In line with our ancestors: Oct-4 and the mammalian germ. Bioessays 1998;20:722-732.
93. Reubinoff BE, Pera MF, Fony CY et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 2000;18:399-404.
94. Mitalipov SM, Kuo HC, Hennebold JD et al. Oct-4 expression in pluripotent cells of the Rhesus monkey. Biol Reprod 2003;69:1785-1792.
95. Chambers I, Colby D, Robertson M et al. Functional expres-sion cloning of nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003;113:643-655.
96. Mitsui K, Tokuzawa Y, Itoh H et al. The homeoprotein nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003;113:631-642.
97. Durick K, Mendlein J, Xanthopoulos KG. Hunting with traps: genome-wide strategies for gene discovery and functional analysis. Genome Res 1999;9:1019-1025.
98. Zambrowicz BP, Friedrich GA. Comprehensive mammalian genetics: history and future prospects of gene trapping in the mouse. Int J Dev Biol 1998;42:1025-1036.
99. Zambrowicz BP, Friedrich GA, Buxton EC et al. Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells. Nature 1998;392:608-611.
100. Skarnes WC, Auerbach BA, Joyner AL. A gene trap approach in mouse embryonic stem cells: the lacZ reported is activated by splicing, reflects endogenous gene expression, and is mutagenic in mice. Genes Dev 1992;6:903-918.
101. Bolon B, Galbreath E. Use of genetically engineered mice in drug discovery and development: wielding Occam's razor to prune the product portfolio. Int J Toxicol 2002;21:55-64.
102. Zambrowicz BP, Sands AT. Knockouts model the 100 best-selling drugs: will they model the next 100? Nat Rev Drug Discov 2003;2:38-51.
103. Sasai Y. Generation of dopaminergic neurons from embryonic stem cells. J Neurol 2002;249(suppl 2):II41-II44.
104. Deacon T, Dinsmore J, Costantini LC et al. Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation. Exp Neurol 1998;149:28-41.
105. Wakayama T, Tabar V, Rodriguez I et al. Differentiation of embryonic stem cell lines generated from adult cells by nuclear transfer. Science 2001;292:740-743.
106. Kim JH, Auerbach JM, Rodriguez-Gomez JA et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002;418:50-56.
107. Barberi T, Klivenyi P, Calingasan NY et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol 2003;21:1200-1207.
108. Kawasaki H, Suemori H, Mizuseki K et al. Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc Natl Acad Sci U S A 2002;99:1580-1585.
109. Paterson L, DeSousa P, Ritchie W et al. Application of reproductive biotechnology in animals: implications and potentials. Applications for reproductive cloning. Anim Reprod Sci 2003;79:137-143.
110. Campbell KHS, McWhir J, Ritchie WA et al. Sheep cloned by nuclear transfer from a cultured cell line. Nature 1996;380:64-66.
111. Wilmut I, Schnieke AE, McWhir J et al. Viable offspring derived from fetal and adult mammalian cells. Nature 1997;385:810-813.
112. Cibelli JB, Stice SL, Golueke PJ et al. Cloned transgenic calves produced from nonquiescent fetal fibroblasts. Science 1998;280:1256-1258.
113. Wakayama T, Perry ACF, Zuccotti M et al. Full term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 1998;394:369-374.
114. Baguisi A, Behboodi E, Melican DT et al. Production of goats by somatic cell nuclear transfer. Nat Biotechnol 1999;17:456-461.
115. Polejaeva IA, Chen SH, Vaught TD et al. Cloned pigs produced by nuclear transfer from adult somatic stem cells. Nature 2000;407:86-90.
116. Denning C, Burl S, Ainslie A et al. Deletion of the alpha(1,3)galactosyl transferase (GGTA1) gene and the prion protein (PrP) gene in sheep. Nat Biotechnol 2001;19:559-562.
117. Thomson JA, Kalishman J, Golos T G et al. Isolation of aprimate embryonic stem cell line. Proc Natl Acad Sci U S A 1995;92:7844-7848.
118. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
119. Shevinshky LH, Knowles BB, Damjanov I et al. Monoclonal anitbody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 1982;30:697-705.
120. Kannagi R, Cochran NA, Ishigami F et al. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J 1983;2:2355-2361.
121. Andrews PW, Goodfellow PN, Shevinshky LH et al. Cell surface antigens of a clonal human embryonal carcinoma cell line: morphologic and antigenic differentiation in culture. Int J Cancer 1982;29:523-531.
122. Bernstine EG, Hooper ML, Grandchamp S et al. Alkaline phosphatase activity in mouse teratoma. Proc Natl Acad Sci U S A 1973;70:3899-3903.
123. McBurney MW, Rogers BJ. Isolation of male embryonal carcinoma cells and their chromosome replication patterns. Dev Biol 1982;89:503-508.
124. Kundu RK, Sangiorgi F, Wu LY et al. Targeted inactivation of the coagulation factor IX gene causes hemophilia B in mice. Blood 1998;92:168-174.
125. Sitailo S, Sood R, Barton K et al. Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements. Leukemia 1999;13:1639-1645.
126. Ciavatta DJ, Ryan TM, Farmer SC et al. Mouse model for human beta zero thalassemia: targeted deletion of the mouse beta maj- and beta min-globin genes in embryonic stem cells. Proc Natl Acad Sci U S A 1995;92:9259-9263.
127. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995;270:1203-1207.
128. Hooper ML, Hardy K, Handyside A et al. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature (London) 1987;326:292-295.
129. Ishibashi S, Brown MS, Goldstein JL et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993;92:2883-2893.
130. Patejunas G, Bradley A, Beaudet AL et al. Generation of a mouse model for citrullinemia by targeted disruption of the argininosuccinate synthetase gene. Somat Cell Mol Genet 1994;20:55-60.
131. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992;69:915-926.
132. Sango K, Yamanaka S, Hoffmann A et al. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat Genet 1995;11:170-176.
133. Nagy A, Rossant J, Nagy R et al. Derivation of completely cell-culture derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A 1993;90:8424-8428.
134. Soria B, Roche E, Berna G et al. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 2000;9:157-162.
135. Dardenne O, Prud'homme J, Arabian A et al. Targeted inactivation of the 25-hydroxy vitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001;142:3135-3141.
136. Kawagoe K, Kitamura D, Okabe M et al. Glycosylphosphatidylinositol- anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria. Blood 1996;87:3600-3606.